Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - October 16, 2007
Raymond Baguma
Kirumira is the founder and chief executive officer of BioMedica Diagnostics, a medical biotechnology company based in Windsor, Canada.
He will be recognised for inventing one of the world's first rapid HIV-testing kits.
A 25-member panel of The Economist innovation award, chaired by Tom Standage, the magazine's business editor, selected Kirumira.
The award will be presented to him tomorrow by John Micklethwait, the editor-in-chief, at the London Science Museum, during the magazine's Sixth Annual Innovation Awards.
"You have been chosen by The Economist to receive our innovation award in the area of bioscience for the contributions you have made with regard to the development of rapid diagnostic HIV testing," reads a letter from Standage to Kirumira.
The magazine recognises successful innovators in bioscience, computing and telecommunications, energy and the environment, social and economic innovation, consumer products, and the 'no boundaries' category.
Kirumira will be recognised as a top innovator of 2007 and will receive the award under the bioscience category.
Also to be recognised in the same category is Hermes Chan, the president of MedMira, a company that manufactures diagnostic testing kits.
It is located in Halifax, Canada.
According to Standage, the awards are given to individuals, rather than institutions for which they work.
They do not involve cash prizes but include recognition in the pages of the magazine. Kirumira studied at Kamuli Primary School in Bugere and later joined Kibuli Secondary School.
He attained a degree in Medicine from Makerere University.
His mother, Maimuna Nabagereka, yesterday said: "He last came to visit us early this year. We had not received the news of his award. We will organise a party to congratulate him." upon the award."
071016
NV071008
Copyright © 2007 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .